论文部分内容阅读
目的分析规范化指导沙美特罗氟替卡松干粉吸入剂的正确使用对支气管哮喘的临床治疗效果。方法 69例支气管哮喘患者,根据用药指导差异分为甲组(35例)和乙组(34例)。甲组患者给予沙美特罗氟替卡松干粉吸入剂常规性引导治疗,乙组患者给予沙美特罗氟替卡松干粉吸入剂规范化指导治疗,比较两组患者的治疗效果。结果乙组患者治疗总有效率为88.2%,高于甲组的68.6%,差异具有统计学意义(P<0.05)。结论规范化指导沙美特罗氟替卡松干粉吸入剂的使用对支气管哮喘患者的病情起到明显的缓解作用,值得推广应用。
Objective To analyze the clinical effect of standardized use of salmeterol fluticasone dry powder inhaler on bronchial asthma. Methods Sixty-nine patients with bronchial asthma were divided into group A (35 cases) and group B (34 cases) according to the difference of medication guidance. Patients in group A were given routine guided therapy of salmeterol fluticasone dry powder inhalation. Patients in group B were treated with salmeterol fluticasone dry powder inhalation. The treatment effect was compared between the two groups. Results The total effective rate of treatment in group B was 88.2%, which was higher than 68.6% in group A, the difference was statistically significant (P <0.05). Conclusion The standardized use of salmeterol fluticasone dry powder inhalation has a significant relieving effect on the patients with bronchial asthma, which is worth popularizing and applying.